Deutsche Bank Ag\ Igm Biosciences, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 11,203 shares of IGMS stock, worth $71,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,203

Previous 10,849 3.26%

Holding current value

$71,699

Previous $74,000 150.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.28 - $17.68 $2,223 - $6,258	354 Added 3.26%	11,203 $185,000
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $34,516 - $60,813	5,302 Added 95.58%	10,849 $74,000
Q1 2024 May 15, 2024	SELL	$8.68 - $17.36 $53,425 - $106,850	-6,155 Reduced 52.6%	5,547 $53,000
Q4 2023 Feb 14, 2024	BUY	$3.94 - $8.79 $46,105 - $102,860	11,702 New	11,702 $97,000
Q2 2023 Aug 14, 2023	SELL	$8.86 - $14.0 $19,119 - $30,212	-2,158 Reduced 30.3%	4,965 $45,000
Q1 2023 May 15, 2023	BUY	$13.74 - $25.76 $24,663 - $46,239	1,795 Added 33.69%	7,123 $97,000
Q4 2022 Feb 13, 2023	SELL	$15.45 - $26.02 $68,505 - $115,372	-4,434 Reduced 45.42%	5,328 $90,000
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $59,212 - $103,718	3,840 Added 64.84%	9,762 $222,000
Q2 2022 Aug 11, 2022	BUY	$13.27 - $25.5 $15,658 - $30,090	1,180 Added 24.88%	5,922 $107,000
Q1 2022 May 13, 2022	SELL	$13.42 - $29.73 $6,535 - $14,478	-487 Reduced 9.31%	4,742 $127,000
Q4 2021 Feb 11, 2022	BUY	$27.59 - $66.39 $7,173 - $17,261	260 Added 5.23%	5,229 $154,000
Q3 2021 Nov 04, 2021	SELL	$65.76 - $90.65 $10,521 - $14,504	-160 Reduced 3.12%	4,969 $327,000
Q2 2021 Aug 11, 2021	BUY	$57.98 - $96.6 $14,842 - $24,729	256 Added 5.25%	5,129 $426,000
Q1 2021 May 13, 2021	SELL	$71.56 - $121.23 $302,054 - $511,711	-4,221 Reduced 46.42%	4,873 $373,000
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $244,730 - $593,784	5,162 Added 131.28%	9,094 $803,000
Q3 2020 Nov 12, 2020	SELL	$43.0 - $84.01 $10,535 - $20,582	-245 Reduced 5.87%	3,932 $290,000
Q2 2020 Aug 13, 2020	BUY	$51.3 - $75.21 $124,197 - $182,083	2,421 Added 137.87%	4,177 $304,000
Q1 2020 May 14, 2020	SELL	$31.51 - $73.75 $2,331 - $5,457	-74 Reduced 4.04%	1,756 $98,000
Q4 2019 Feb 14, 2020	BUY	$17.25 - $49.51 $31,567 - $90,603	1,830 New	1,830 $69,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $185M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account